Japan stocks rally, yen slides as PM Ishiba’s resignation sparks fiscal jitters
LONDON - Investment management giant BlackRock, Inc. has reduced its stake in CVS Group plc to below 5%, according to a regulatory filing released Friday.
The notification of major holdings shows that BlackRock crossed below the reporting threshold on September 3, 2025, with the veterinary services company being notified the following day.
Prior to the reduction, BlackRock held a 5.06% stake in CVS Group, consisting of 4.46% in voting rights attached to shares and 0.59% through financial instruments. The current position is now reported as "below 5%" across all categories.
The filing indicates BlackRock’s holdings include direct ownership of shares, securities lending arrangements, and contracts for difference (CFDs). The investment is managed through multiple BlackRock subsidiaries across its global operations.
The disclosure, made in accordance with the UK’s Disclosure Guidance and Transparency Rules, is a standard requirement when an institutional investor crosses certain ownership thresholds in publicly traded companies.
CVS Group, listed on the London Stock Exchange, operates veterinary practices, diagnostic laboratories, and pet crematoria across the United Kingdom.
The regulatory announcement did not specify reasons for BlackRock’s reduction in its position or indicate whether the change was part of a broader portfolio adjustment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.